Nimesulide decreases superoxide production by inhibiting phosphodiesterase type IV
- 16 August 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 268 (3) , 415-423
- https://doi.org/10.1016/0922-4106(94)90067-1
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Nimesulide Inhibits Platelet-Activating Factor Synthesis in Activated Human NeutrophilsDrugs, 1993
- Activation of Protein Kinase C by Respiratory Burst Stimulants Desensitises β2-Adrenoceptors on Human NeutrophilsClinical Drug Investigation, 1991
- Tumor necrosis factor and CD11/CD18 (beta 2) integrins act synergistically to lower cAMP in human neutrophils.The Journal of cell biology, 1990
- Inhibitory effect of cyclic AMP on phorbol ester-stimulated production of reactive oxygen metabolites in rat glomeruliBiochemical and Biophysical Research Communications, 1989
- NimesulideDrugs, 1988
- Inhibition of neutrophil oxidative metabolism by nimesulideInflammation Research, 1987
- Inhibition of inositol phospholipids metabolism and calcium mobilization by cyclic AMP-increasing agents and phorbol ester in neutrophilsBiochemical and Biophysical Research Communications, 1986
- Stimulus-dependent inhibition of superoxide generation by prostaglandinsClinical Immunology and Immunopathology, 1985
- Diacylglycerol, 1-oleoyl-2-acetyl-glycerol, stimulates superoxide-generation from human neutrophilsBiochemical and Biophysical Research Communications, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976